A downregulation of expression of OCLN and CLDN-3, -4, and -7 has been observed in endometriosis [84], and an upregulation of expression of CLDN-3 and -4 has been reported in endometrial cancer [85]. This evidence concerns the gene CLDN3 and endometrial cancer.